Corrigendum to "Exploring the role of accessory biomarkers TMB, STK11, KEAP1, and KRAS in non-small-cell lung cancer: confused, but on a much higher level": [Annals of Oncology 34 (2023) 327-332]
- PMID: 37296057
- DOI: 10.1016/j.annonc.2023.05.007
Corrigendum to "Exploring the role of accessory biomarkers TMB, STK11, KEAP1, and KRAS in non-small-cell lung cancer: confused, but on a much higher level": [Annals of Oncology 34 (2023) 327-332]
Erratum for
-
Exploring the role of accessory biomarkers TMB, STK11, KEAP1, and KRAS in non-small-cell lung cancer: confused, but on a much higher level.Ann Oncol. 2023 Apr;34(4):327-332. doi: 10.1016/j.annonc.2023.02.013. Ann Oncol. 2023. PMID: 37061249 No abstract available.
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous
